Synthesis of Best-Seller Drugs, Volume Two, Second Edition provides detailed information on the most popular drugs using a practical layout arranged according to drug type. Each chapter reviews the main drugs in each of nearly 40 key therapeutic areas while also examining their classification, novel structural features, models of action, and synthesis. Of high interest to all those who work in the captivating areas of biologically active compounds and medicinal drug synthesis, in particular medicinal chemists, biochemists, and pharmacologists, the book aims to support current research efforts while also encouraging future developments in this important field.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. (23). Drugs for Treating Respiratory System Diseases2. (24). Novel Structural Features and Advances in Antithrombotic Drugs (anticoagulant, antiplatelet, and thrombolytic drugs)
3. (25). Thyroid and Antithyroid Drugs
4. (26). Hyperglycemic and Hypoglycemic Drugs
5. (27). Steroid Hormones
6. (28). Antineoplastic Agents
7. (29). Immunopharmacological Drugs
8. (30). Antibiotics
9. (31). Antibacterial drugs
10. (32). Antimycobacterial drugs
11. (33). Antifungal drugs
12. (34). Antiviral drugs
13. (35). Drugs for treating protozoan infections
14. (36). Anthelmintics
15. (37). Proton pump inhibitors
16. (38). Drugs for treatment of erectile dysfunction
17. (39). Antiobesity drugs
Authors
Ruben Vardanyan Research Professor, Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA. Research Professor, Department of Chemistry and Biochemistry, University of Arizona Gayane Vardanyan Professor of Biochemistry Department, Yerevan State Medical University, Armenia.Gayane Vardanyan Professor of Biochemistry Department, Yerevan State Medical University, teaching a general course in biochemistry.
She conducts studies on the neurochemical mechanisms of pain, investigates the functioning of the brain reward system during formation of obesity, as well as manages research work on the possible role of disturbances in the processes of opioidergic neurotransmission during development of diabetic neuropathy.
